Alpha 2.0
Login Register
» Authors » M Galiano

M Galiano

Explore the profile of M Galiano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 536
Followers 0
Related Specialties
Urology
Infectious Diseases
Neurology
Top 10 Co-Authors
E Barret
X Cathelineau
R Sanchez-Salas
F Rozet
D Prapotnich
N Cathala
A Mombet
A Sivaraman
M Zambon
J Ellis
Published In
Prog Urol
Euro Surveill
Actas Urol Esp
Actas Urol Esp (Engl Ed)
Neurologia
Affiliations
Soon will be listed here.
Recent Articles
1.
Immediate versus delayed prostatectomy and the fate of patients who progress to a higher risk disease on active surveillance
Mallya A, Senguttuvan-Karthikeyan V, Sivaraman A, Barret E, Galiano M, Cathala N, et al.
Actas Urol Esp (Engl Ed) . 2019 Apr; 43(6):324-330. PMID: 30928176
Introduction: Oncological outcomes of radical prostatectomy (RP) in patients progressing on active surveillance (AS) are debated. We compared outcomes of AS eligible patients undergoing RP immediately after diagnosis with those...
2.
Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors
Senguttuvan Karthikeyan V, Mallya A, Sivaraman A, Galiano M, Rozet F, Cathala N, et al.
Actas Urol Esp (Engl Ed) . 2019 Mar; 43(5):234-240. PMID: 30857765
Introduction: The significance of upstaging of cT1 renal tumors to pT3a is not clear. We evaluate the incidence of upstaging, identify predictors and analyze oncological outcomes of these patients versus...
3.
Predictors of early, intermediate and late biochemical recurrence after minimally invasive radical prostatectomy in a single-centre cohort with a mean follow-up of 8 years
Garcia-Barreras S, Nunes I, Srougi V, Secin F, Baghdadi M, Sanchez-Salas R, et al.
Actas Urol Esp (Engl Ed) . 2018 Apr; 42(8):516-523. PMID: 29606285
Objective: To determine the predictors of early, intermediate and late biochemical recurrence (BR) following minimally invasive radical prostatectomy in patients with localised prostate cancer (PC). Material And Methods: We included...
4.
Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy
Garcia-Barreras S, Rozet F, Nunes-Silva I, Srougi V, Sanchez-Salas R, Barret E, et al.
Clin Transl Oncol . 2017 Dec; 20(8):1004-1010. PMID: 29243074
Purpose: To evaluate predictive factors associated with detectable prostate-specific antigen (PSA) and describe clinical recurrence (CR) and cancer-specific mortality (CSM) after robot-assisted radical prostatectomy (RARP). Methods: The study included 2500...
5.
[Management of ablative therapies in prostate cancer]
Barret E, Sanchez-Salas R, Galiano M, Cathala N, Mombet A, Prapotnich D, et al.
Prog Urol . 2017 Sep; 27(15):909-925. PMID: 28918872
Objectives: To describe the specific modalities of ablative therapies management in prostate cancer. Materials And Methods: A review of the scientific literature was performed in Medline database (http://www.ncbi.nlm.nih.gov) and Embase...
6.
Impact of neoadjuvant chemotherapy on complications of minimally invasive radical cystectomy
Lizee D, Salas R, Barret E, Galiano M, Di Trapani E, Montorsi F, et al.
Actas Urol Esp . 2016 Dec; 41(2):88-96. PMID: 27908636
Background: Neoadjuvant chemotherapy (NC) before minimally invasive radical cystectomy (MIRC) is considered a standard of care in muscle-invasive bladder cancer or recurrent high-risk non-muscle-invasive bladder cancer. Objective: To evaluate the...
7.
Systematic review of perioperative outcomes and complications after open, laparoscopic and robot-assisted radical cystectomy
Palazzetti A, Sanchez-Salas R, Capogrosso P, Barret E, Cathala N, Mombet A, et al.
Actas Urol Esp . 2016 Dec; 41(7):416-425. PMID: 27908634
Radical cystectomy and regional lymph node dissection is the standard treatment for localized muscle-invasive and for high-risk non-muscle-invasive bladder cancer, and represents one of the main surgical urologic procedures. The...
8.
Higher number of transrectal ultrasound guided prostate biopsy cores is associated with higher blood loss and perioperative complications in robot assisted radical prostatectomy
Carneiro A, Sivaraman A, Sanchez-Salas R, Nunes-Silva I, Baghdadi M, Srougi V, et al.
Actas Urol Esp . 2016 Nov; 41(3):155-161. PMID: 27890493
Introduction: The local inflammatory process after prostate biopsies can have a negative impact on functional outcomes of radical prostatectomy. There is no evidence in literature demonstrating its impact on radical...
9.
High intensity focused ultrasound with Focal-One device: Prostate-specific antigen impact and morbidity evaluation during the initial experience
Perez-Reggeti J, Sanchez-Salas R, Sivaraman A, Linares Espinos E, de Gracia-Nieto A, Barret E, et al.
Actas Urol Esp . 2016 Aug; 40(10):608-614. PMID: 27543259
Objective: We report our initial experience in the treatment of prostate cancer (PCa) with high-intensity focused ultrasound (HIFU) using the Focal-One device. Material And Methods: Retrospective review of the prospectively...
10.
Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer
Ahallal Y, Sanchez-Salas R, Sivaraman A, Barret E, Secin F, Validire P, et al.
Actas Urol Esp . 2016 Aug; 40(10):615-620. PMID: 27527686
Objectives: To evaluate the role of Transperineal Template guided Mapping Biopsy (TTMB) in determining the management strategy in patients with low risk prostate cancer (PCa). Methods: We retroscpectively evaluated 169...